JENNIFER MARINO: Open Payments
NPI 1407323298 · WYNNEWOOD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$669 in 32 payments from 17 companies in 2025. Trend: 2023 $358 · 2024 $493 · 2025 $669
Food & beverage: $669
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC | 5 | $98 |
| Merz Pharmaceuticals, LLC | 3 | $73 |
| PFIZER INC. | 3 | $70 |
| Teva Pharmaceuticals USA, Inc. | 4 | $66 |
| ABBVIE INC. | 2 | $49 |
| ARGENX US, INC. | 2 | $42 |
| Neurocrine BioSciences, Inc. | 2 | $39 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Globus Medical, Inc. | 1 | $34 |
| CSL Behring | 1 | $29 |
Products named: ONGENTYS, AUSTEDO XR, INBRIJA, VYALEV, VYVGART HYTRULO, ZAVZPRET, INGREZZA, WAINUA.
Industry payments across PA — which companies pay providers there.
